Definitive Healthcare Insider Filing Shows No Shares Held by New CLO

Rhea-AI Filing Summary

Definitive Healthcare Corp. (DH) – Form 3 filing

The filing records the initial beneficial ownership position of newly listed insider Jonathan Paris, who became Chief Legal Officer on 16 June 2025. According to the disclosure, Paris currently reports no direct or indirect ownership of DH securities. An Exhibit 24 Power of Attorney is included, authorising future Section 16 filings on his behalf. No derivatives, options, or other equity instruments are listed. The submission is made on an individual basis and bears a manual signature dated 18 June 2025.

Because no securities are owned and no transactions are reported, the document is largely administrative and carries minimal immediate financial impact for investors.

Insights

Corporate Governance Analyst

TL;DR: New officer files Form 3 showing zero ownership—purely procedural, negligible market impact.

This Form 3 merely registers Jonathan Paris as a Section 16 insider following his appointment as Chief Legal Officer. He reports no share or derivative holdings, so there is no dilution or insider-confidence signal. The filing satisfies compliance requirements but offers investors little actionable information. Unless future Forms 4 disclose purchases, this update should not influence valuation or governance risk assessments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 06/18/2025 - 07:04 PM Learn about SEC filing dates

FAQ

Who is the reporting person in Definitive Healthcare's (DH) June 2025 Form 3?

The reporting person is Jonathan Paris, recently appointed Chief Legal Officer.

Does Jonathan Paris own any Definitive Healthcare (DH) shares or derivatives?

The Form 3 states no securities are beneficially owned, whether direct or indirect.

Why was this Form 3 filed?

Section 16 requires new officers like the Chief Legal Officer to file an initial statement of beneficial ownership when they become insiders.

What is the effective date of Jonathan Paris becoming an insider at DH?

The event date triggering the filing is June 16, 2025.

Does the filing include a Power of Attorney?

Yes, Exhibit 24 – Power of Attorney authorises future Section 16 filings on Jonathan Paris’s behalf.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Paris Jonathan

(Last) (First) (Middle)

C/O DEFINITIVE HEALTHCARE CORP.

492 OLD CONNECTICUT PATH, SUITE 401

(Street)

FRAMINGHAM MA 01701

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/16/2025

3. Issuer Name and Ticker or Trading Symbol
Definitive Healthcare Corp. [ DH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Jonathan Paris	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.